Airway Extubation Clinical Trial
Official title:
Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool
NCT number | NCT04708509 |
Other study ID # | 2681 |
Secondary ID | |
Status | Recruiting |
Phase | Phase 1 |
First received | |
Last updated | |
Start date | October 4, 2021 |
Est. completion date | February 2023 |
Expeditious, safe extubation is vitally important in the care of Intensive Care Unit (ICU) patients, as prolonged mechanical ventilation harms patients and failed extubation (i.e. re-intubation within 48 hrs) is associated with increased morbidity, mortality and costs. The urgent need to improve extubation failure is further highlighted by current observations suggesting that COVID-19 patients are at increased risk of both early and late extubation failure. The investigators previously found that decreased respiratory rate variability (indicative of reduced adaptability and/or increased stress) during Spontaneous Breathing Trials (SBTs) predicted extubation failure and outperformed the best available predictive indices. Combining this predictive analytic with standardized extubation readiness checklists and risk mitigation strategies, the investigators created the Extubation Advisor (EA). The investigators recently completed a single-center phase I mixed methods observational study (n=117) wherein there was demonstrated technical feasibility (i.e. ability to generate 92% EA of reports) and clinician acceptance of the EA tool. In the current open-label, multi-center interventional phase I study, the investigators will assess the feasibility and initial perceptions of EA implementation in the intensive care unit by (1) evaluating the feasibility of patient enrolment, data collection, and EA report generation, and (2) performing a mixed-methods analysis of critical care physician and respiratory therapist perceptions of EA. Findings from this study will inform a future randomized controlled trial assessing EA outcomes compared to standard of care, with the intent of aiding bedside decision-making, enhancing care delivery, and improving outcomes in critically ill patients with and without COVID-19.
Status | Recruiting |
Enrollment | 72 |
Est. completion date | February 2023 |
Est. primary completion date | January 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - In the Intensive Care Unit (ICU) - Able to provide informed consent (through a surrogate) - Invasive mechanical ventilation for > 48 hours - Ready for spontaneous breathing test (SBT) for assessment for extubation - At least partial reversal of the condition precipitating mechanical ventilation - Stabilization of other organ systems - Toleration of pressure support ventilation less than or equal to 14 cm H2O, (oxygen saturation (SpO2) greater than or equal to 90% with fraction of inspired oxygen (FiO2) less than or equal to 40% and positive end-expiry pressure (PEEP) less than or equal to 10cm H2O) - Hemodynamic stability (low - phenylephrine less than 50 ug/min; norepinephrine less than 5 ug/min; dobutamine less than 5 ug/kg/min; milrinone less than 0.4 ug/kg/min - or no vasopressors) - Stable neurological status (no deterioration in Glasgow coma score during prior 24 hours and, if measured, intracranial pressure (ICP) less than 20 mmHg) - Intact airway reflexes (adequate cough with suctioning and a gag reflex) - Normal sinus rhythm at the time of the SBT (no pacemaker) Exclusion Criteria: - Order not to re-intubate should the patient fail extubation - Anticipated withdrawal of life support - Known or suspected severe weakness (myopathy, neuropathy, or quadriplegia) - Tracheostomy - Prior extubation during current ICU stay |
Country | Name | City | State |
---|---|---|---|
Canada | The Ottawa Hospital, General Campus | Ottawa | Ontario |
Lead Sponsor | Collaborator |
---|---|
Ottawa Hospital Research Institute |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluate feasibility of enrolling and consenting greater than 50% of eligible patients | Feasibility of patient enrolment and consent will be evaluated by determining if greater than 50% of eligible patients are enrolled and consented | Upon study completion, 4 months after study initiation | |
Primary | Evaluate feasibility of capturing greater than 75% of wave form data | Feasibility of wave form data capture will be evaluated by determining if greater than 75% of the time, wave form data is captured | Upon study completion, 4 months after study initiation | |
Primary | Evaluate feasibility of entering greater than 90% of participant clinical data into the Extubation Advisor tool | Feasibility of participant clinical data entry will be evaluated by determining if greater than 90% of the time, participant clinical data is fully entered into the Extubation Advisor tool | Upon study completion, 4 months after study initiation | |
Primary | Evaluate feasibility of generating and delivering greater than 80% of Extubation Advisor reports to the attending physician | Feasibility of Extubation Advisor report generation will be evaluated by determining if greater than 80% of the time, an extubation report is successfully generated and delivered to the attending physician | Upon study completion, 4 months after study initiation | |
Primary | Evaluate opinions of Physicians and Respiratory Therapists regarding Extubation Advisor | Usability, perceived value, identified behaviours, perceived barriers and drivers, and perceived impact will be assessed through interviews with respiratory therapists and attending physicians | Upon study completion, 4 months after study initiation | |
Secondary | Evaluate feasibility of completing greater than 90% of clinical CRFs | Feasibility of completing the clinical case report forms will be evaluated by determining if greater than 90% of the time, clinical CRFs are complete | Upon study completion, 4 months after study initiation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05114551 -
ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure
|
||
Recruiting |
NCT06154811 -
Exploring the Use of Pulse Tissue Doppler in Predicting Extubation Success in Mechanically Ventilated Patients
|
||
Recruiting |
NCT06110390 -
High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients
|
N/A | |
Completed |
NCT04356625 -
Maximum Expiratory Pressure in Induced Cough as a Predictor of Extubation Failure
|
N/A | |
Not yet recruiting |
NCT05506904 -
Liberation From Mechanical Ventilation Using Extubation Advisor Decision Support
|
Phase 1 | |
Recruiting |
NCT05999526 -
Mechanical Ventilation Reconnection for One Hour After Spontaneous Breathing Trial
|
N/A | |
Completed |
NCT02799056 -
Diaphragmatic and Pulmonary US for Extubation Success Prediction
|
||
Not yet recruiting |
NCT04266535 -
TCI vs Manually Controlled Infusion of Propofol
|
||
Enrolling by invitation |
NCT05523479 -
The Maximizing Extubation Outcomes Through Educational and Organizational Research (METEOR) Trial
|
N/A | |
Completed |
NCT01513772 -
The Effect of Dexmedetomidine on the Emergence Agitation in Nasal Surgery
|
N/A | |
Completed |
NCT03495947 -
High Flow Nasal Cannula in Immediately Post Extubation
|
||
Recruiting |
NCT03946371 -
Relation Between the Volume of Subglottic Secretion and Risk of Extubation Failure in ICU Patients (SEGEX)
|
||
Recruiting |
NCT05356299 -
Analysis of the Magnetic Tape Bandage on Respiratory Functional Effects.
|
N/A |